Provided by Tiger Trade Technology Pte. Ltd.

Arcus Biosciences Inc.

25.54
+0.89003.61%
Post-market: 25.540.00000.00%19:30 EDT
Volume:2.01M
Turnover:51.49M
Market Cap:3.25B
PE:-6.61
High:25.92
Open:25.31
Low:25.05
Close:24.65
52wk High:31.74
52wk Low:11.68
Shares:127.33M
Float Shares:89.84M
Volume Ratio:0.80
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8641
EPS(LYR):-3.2900
ROE:-90.82%
ROA:-30.39%
PB:7.01
PE(LYR):-7.76

Loading ...

Press Release: Arcus Biosciences to Host Conference Call to Discuss Second-quarter 2026 Financial Results and Pipeline Updates

Dow Jones
·
Jul 22

Arcus Biosciences Schedules Call on Second-quarter Financial Results and Pipeline Update

Reuters
·
Jul 22

Arcus Biosciences is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 20

Arcus Biosciences price target raised to $45 from $32 at H.C. Wainwright

TIPRANKS
·
Jul 20

Arcus Biosciences President Juan C. Jaen Disposes of $2.05 Million in Common Shares

Reuters
·
Jul 14

Arcus Biosciences Grants Inducement Stock Options for 16,060 Shares at $30.26 Each

Reuters
·
Jul 10

Arcus Biosciences announces publication on ARC-20 study research

TIPRANKS
·
Jul 01

Arcus Biosciences Opens New Front With First-In-Human Trial of AB102

TIPRANKS
·
Jun 26

Arcus Bio President Juan C. Jaen Disposes of USD 852,805 in Common Shares

Reuters
·
Jun 25

Arcus Biosciences Grants New Hires Options for 18,400 Shares at $28.18 Each

Reuters
·
Jun 25

Arcus Biosciences shareholders re-elect Class II directors at annual meeting

Reuters
·
Jun 13

Is Arcus Biosciences (RCUS) Using the ROSETTA Trial Tie-Up to Quietly Reframe Its RCC Strategy?

Simply Wall St.
·
Jun 12

Mizuho Securities Sticks to Its Buy Rating for Arcus Biosciences (RCUS)

TIPRANKS
·
Jun 11

Arcus Biosciences grants new hire options for 2,850 shares, RSUs for 1,450 shares under inducement plan

Reuters
·
Jun 10

Arcus Biosciences Initiated at Outperform by LifeSci Capital

Dow Jones
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Arcus Biosciences (RCUS) and Dyne Therapeutics (DYN)

TIPRANKS
·
Jun 04

Arcus enters clinical trial collaboration, supply agreement with Bristol Myers

TIPRANKS
·
Jun 03

Arcus to Supply Experimental Kidney Cancer Drug for Myers Squibb Trial

Dow Jones
·
Jun 03

Arcus Biosciences, Bristol Myers Squibb team up to test casdatifan combo in kidney cancer trial

Reuters
·
Jun 03

Arcus Biosciences - Announces Clinical Trial Collaboration With Bristol Myers Squibb

THOMSON REUTERS
·
Jun 03